Cutaneous mastocytosis in childhood.

Katja Nemat, Susanne Abraham
{"title":"Cutaneous mastocytosis in childhood.","authors":"Katja Nemat,&nbsp;Susanne Abraham","doi":"10.5414/ALX02304E","DOIUrl":null,"url":null,"abstract":"<p><p>Mastocytoses are characterized by clonal proliferation of mast cells in various tissues. In childhood, cutaneous mastocytosis (CM) occurs almost exclusively. It is confined to the skin, and has a good prognosis. The most common form is the maculopapular cutaneous mastocytosis (MPCM), formerly called urticaria pigmentosa. A distinction is made between a monomorphic variant of MPCM with multiple small, roundish maculopapular skin lesions and the - more common - polymorphic variant with larger lesions of variable size. One quarter of CM diagnosed in childhood are mastocytomas, which often occur solitary or at multiple sites. The diffuse variant of CM (DCM), which affects 5% of children with CM, should be distinguished from these forms. Systemic mastocytoses (SM) with mast cell infiltrates in the bone marrow or other extracutaneous tissues, such as the gastrointestinal tract, occur predominantly in adults. The diagnosis of CM is usually made clinically: Manifestation in infancy, typical morphology and distribution, pathognomonic Darier sign. Basal serum tryptase is determined if DCM or systemic mastocytosis are to be diagnosed. Children with mastocytosis should be managed in a specialized outpatient clinic. For affected families, detailed information about the clinical picture including prognosis assessment is essential. Mast cell mediated symptoms are controlled by oral non-sedating antihistamines if needed.</p>","PeriodicalId":7485,"journal":{"name":"Allergologie Select","volume":"6 ","pages":"1-10"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750954/pdf/","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergologie Select","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5414/ALX02304E","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Mastocytoses are characterized by clonal proliferation of mast cells in various tissues. In childhood, cutaneous mastocytosis (CM) occurs almost exclusively. It is confined to the skin, and has a good prognosis. The most common form is the maculopapular cutaneous mastocytosis (MPCM), formerly called urticaria pigmentosa. A distinction is made between a monomorphic variant of MPCM with multiple small, roundish maculopapular skin lesions and the - more common - polymorphic variant with larger lesions of variable size. One quarter of CM diagnosed in childhood are mastocytomas, which often occur solitary or at multiple sites. The diffuse variant of CM (DCM), which affects 5% of children with CM, should be distinguished from these forms. Systemic mastocytoses (SM) with mast cell infiltrates in the bone marrow or other extracutaneous tissues, such as the gastrointestinal tract, occur predominantly in adults. The diagnosis of CM is usually made clinically: Manifestation in infancy, typical morphology and distribution, pathognomonic Darier sign. Basal serum tryptase is determined if DCM or systemic mastocytosis are to be diagnosed. Children with mastocytosis should be managed in a specialized outpatient clinic. For affected families, detailed information about the clinical picture including prognosis assessment is essential. Mast cell mediated symptoms are controlled by oral non-sedating antihistamines if needed.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
儿童皮肤肥大细胞增多症。
肥大细胞增多症的特点是各种组织中肥大细胞的克隆性增殖。在儿童时期,皮肤肥大细胞增多症(CM)几乎完全发生。它局限于皮肤,预后良好。最常见的形式是黄斑丘疹性皮肤肥大细胞增多症(MPCM),以前称为荨麻疹色素沉着。有多个小的、圆形的斑疹丘疹皮肤病变的单形态型MPCM与更常见的多形态型MPCM有较大的、大小不等的病变。在儿童期诊断的CM中,有四分之一是肥大细胞瘤,通常发生在单个或多个部位。CM的弥漫性变异(DCM)影响5%的CM患儿,应与这些形式区分开来。系统性肥大细胞增多症(SM)伴肥大细胞浸润于骨髓或其他皮肤外组织,如胃肠道,主要发生于成人。CM的诊断通常在临床上作出:表现在婴儿期,典型的形态和分布,典型的达里尔征。如果诊断为DCM或全身性肥大细胞增多症,则测定基础血清胰蛋白酶。患有肥大细胞增多症的儿童应该在专门的门诊进行治疗。对于受影响的家庭,有关临床情况的详细信息,包括预后评估是必不可少的。肥大细胞介导的症状如有需要可口服非镇静性抗组胺药控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Vegan diets from an allergy point of view - Position paper of the DGAKI working group on food allergy. Clinical endpoints in allergen immunotherapy: State of the art 2022. Allergic asthma: An indication for allergen immunotherapy. Allergen challenge tests in allergen immunotherapy: State of the art. Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1